1BP-LSD

HIGH RISK

Drugs / Psychedelic / Novel

BEST FOR:Research●●○○○○○○○○2/10

1BP-LSD · 1-BUTANOYL-PROPIONYL-LSD · 1B-P-LSD

LysergamidePsychedelicResearch ChemicalProdrugSerotonergic

Novel lysergamide prodrug of LSD, metabolized in vivo to produce LSD-like psychedelic effects.

— QUICK REFERENCE

ROUTE / DOSAGE

LOW25mcg

STANDARD100mcg

HIGH200mcg+

Note: Swallowing blotters or liquid; undergoes first-pass metabolism to LSD

CYCLE

Max 1x per week 2-week cooldown recommended

BIOAVAILABILITY

High oral (prodrug conversion to LSD)

ACTIVE DURATION

8-12h (subjective)

STORAGE

Refrigerate in dark airtight container protect from UV light and heat to prevent degradation

HALF-LIFE

~5 hours (plasma)

DURATION BREAKDOWN

Total8-12 hours

Onset30-90 min

Come up60-120 min

Peak2-4 hours

Offset2-4 hours

After effects4-12 hours

Duration varies by route, dose, and individual. Source: community reports.

§ 01 — EFFECTS

7 documented

Visual hallucinations

Auditory distortions

Altered perception of time

Euphoria and introspection

Pupil dilation

Increased heart rate

Synesthesia

§ 02 — RISKS

Potential for severe psychological distress and panic reactions

Risk of triggering latent psychiatric conditions (psychosis, schizophrenia)

Cardiovascular stimulation (elevated heart rate and blood pressure)

Unknown toxicity due to lack of pharmacological studies

Potential for accidental overdose due to inconsistent blotter dosing

§ 03 — INTERACTIONS

Interaction data not yet available for this compound.

§ 04 — SCIENCE

1BP-LSD is a relatively obscure novel lysergamide with no published human or animal pharmacological studies. Its effects and safety profile are extrapolated from its structural similarity to LSD and other 1-acyl prodrugs like 1P-LSD and 1cP-LSD. It is assumed to act as a prodrug, converting to LSD after ingestion, though the exact pharmacokinetics of this conversion have not been characterized. All claims about potency, duration, and safety are based on anecdotal reports and structural analogy rather than empirical data.

Disclaimer. Protokol.wiki is an informational reference. Nothing on this site is medical advice. Compounds listed may be unapproved, unregulated, or illegal in your jurisdiction. Consult a licensed physician before use. Data compiled from peer-reviewed literature.

METHODOLOGYCONTRIBUTECONTACT